We are live on ! Find out more
BCM

Brown Capital Management Portfolio holdings

AUM $500M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+25.3%
3 Year Est. Return
+79.24%
5 Year Est. Return
+57.49%
10 Year Est. Return
+614.96%
AUM
$7.5B
AUM Growth
+$649M
Cap. Flow
+$7.18M
Cap. Flow %
0.1%
Top 10 Hldgs %
47.35%
Holding
134
New
5
Increased
62
Reduced
45
Closed
8

Top Buys

Rank Stock Value
1
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$83.1M
2
QGEN icon
Qiagen
QGEN
+$27.6M
3
ABMD
Abiomed Inc
ABMD
+$24.8M
4
PAYC icon
Paycom
PAYC
+$18.9M
5
ELGX
Endologix Inc
ELGX
+$17.7M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$98.4M
2
CGNX icon
Cognex
CGNX
+$68.2M
3
QGENF
QIAGEN NV
QGENF
+$28M
4
ABAX
Abaxis Inc
ABAX
+$16.8M
5
TECH icon
Bio-Techne
TECH
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 49.71%
2 Healthcare 30.59%
3 Industrials 12.69%
4 Materials 4.27%
5 Consumer Discretionary 1.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRMB icon
126
Trimble
TRMB
$13.7B
$214K ﹤0.01%
6,695
-4,646
-41% -$144K
ADNT icon
127
Adient
ADNT
$1.45B
-41,248
Closed -$2.42M
DG icon
128
Dollar General
DG
$28.5B
-9,031
Closed -$669K
PANW icon
129
Palo Alto Networks
PANW
$306B
-31,560
Closed -$658K
PII icon
130
Polaris
PII
$3.35B
-7,486
Closed -$617K
RH icon
131
RH
RH
$2.54B
-7,879
Closed -$242K
SLB icon
132
SLB Ltd
SLB
$79.1B
-2,790
Closed -$234K
THRM icon
133
Gentherm
THRM
$1.18B
-18,142
Closed -$614K
QGENF
134
DELISTED
QIAGEN NV
QGENF
-999,760
Closed -$28M

Similar funds

Brown Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Brown Capital Management held 134 positions worth $7.5B, up 9.5% from $6.85B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Brown Capital Management's Q1 2017 filing shows 5 new, 62 increased, 45 reduced and 8 closed positions. Its largest new stake was Ironwood Pharmaceuticals: 6,078,742 shares worth $86.9M. The largest sale was Incyte, an estimated $98.4M.

By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 48% a quarter earlier, followed by Healthcare and Industrials.

  • Brown Capital Management's largest Q1 2017 buy was Ironwood Pharmaceuticals: 6,078,742 shares worth $86.9M.
  • Brown Capital Management added most to Abiomed Inc in Q1 2017, an estimated $24.8M increase.
  • Brown Capital Management's biggest Q1 2017 reduction was Incyte, cutting an estimated $98.4M.
  • Brown Capital Management fully exited QIAGEN NV in Q1 2017, selling an estimated $28M.
  • Brown Capital Management's ten largest holdings make up 47% of its $7.5B portfolio in Q1 2017.
  • Brown Capital Management opened 5 new positions and closed 8 in Q1 2017.
  • Brown Capital Management's portfolio value rose 9.5% quarter-over-quarter to $7.5B.

Based on Brown Capital Management's 13F filing for Q1 2017, filed 9 May 2017.